BNGO
Bionano Genomics, Inc.NASDAQHealthcare$1.20+0.84%ClosedMarket Cap: $3.9M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
0.15
P/S
0.14
EV/EBITDA
-0.33
DCF Value
$-118.81
FCF Yield
-414.8%
Div Yield
0.0%
Margins & Returns
Gross Margin
22.0%
Operating Margin
-116.9%
Net Margin
-92.6%
ROE
-56.2%
ROA
-38.1%
ROIC
-64.6%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $8.0M | -46.3% | $-8.5M | $-7.9M | $-1.46 | — |
| FY 2025 | $28.5M | 22.0% | $-33.3M | $-26.4M | $-4.85 | — |
| Q3 2025 | $7.4M | 47.8% | $-8.5M | $-8.5M | $-1.59 | — |
| Q2 2025 | $6.7M | 51.6% | $-7.8M | $-6.9M | $-1.99 | — |
| Q1 2025 | $6.5M | 45.5% | $-8.5M | $-3.1M | $-1.15 | — |
| Q4 2024 | $8.2M | 41.9% | $-11.9M | $-20.1M | $-10.79 | — |
| FY 2024 | $30.8M | 1.2% | $-104.0M | $-112.0M | $-88.13 | — |
| Q3 2024 | $6.1M | -139.1% | $-43.9M | $-44.2M | $-30.92 | — |
| Q2 2024 | $7.8M | 33.3% | $-17.0M | $-16.2M | $-14.40 | — |
| Q1 2024 | $8.8M | 32.2% | $-31.1M | $-31.4M | $-35.75 | — |
| Q4 2023 | $10.7M | 22.7% | $-20.0M | $-43.9M | $-3,970.20 | — |
| FY 2023 | $36.1M | 26.5% | $-215.2M | $-232.5M | $-408.60 | — |